Metadifferentiation of iris nevi after iridectomy: a clinicopathological small case series

Détails

ID Serval
serval:BIB_F8FFE3382157
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Titre
Metadifferentiation of iris nevi after iridectomy: a clinicopathological small case series
Titre de la conférence
Acta Ophthalmologica
Auteur(s)
Schalenbourg A., Roberti P., Zografos L.
Organisation
European Association for Vision and Eye Research
Statut éditorial
Publié
Date de publication
2010
Peer-reviewed
Oui
Volume
88
Langue
anglais
Résumé
Abstract
Purpose Iridectomy of suspicious pigmented tumors provides the presumed advantage of both a histopathological diagnosis and treatment of the lesion. We present 2 patients that developed an iris melanoma with extrascleral extension at the site of their iridectomy of a histopathologically proven nevus, 46 and 2.5 years later.
Methods Retrospective, clinicopathological small case series of 2 patients.
Results Two patients underwent iridectomy for a suspicious tumor, the first in 1963 and the second in 2006. Pathological diagnosis was a benign and a borderline nevus respectively. In 2009, both patients presented with a recurrent melanocytic iridociliary tumor with an extrascleral extension adjacent to the surgical scar. Pathological examination confirmed melanoma. Consequently, the two patients underwent proton beam therapy of the whole anterior segment, with limbus deposition and reposition.
Conclusion Iridectomy of a histopathologically proven nevus doesn't exclude the possibility of a metadifferentiation of remaining nevus cells into melanoma, even after 46 years. Additionally, treatment in case of a recurrence is more complicated than a primary radiotherapy of the unbiopsied iris tumor, with clinical proof of growth, would have been.
Création de la notice
04/02/2011 12:24
Dernière modification de la notice
19/03/2018 12:22
Données d'usage